TLSI CIK: 1826667

TriSalus Life Sciences, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.74
FY22:
−32.3
FY23:
−50.6
FY24:
−40.8
FY25:
−18.0
Change from FY21 to FY25
millions USD
FY21:
0.06
FY22:
−1.79
FY23:
−1.59
FY24:
−0.35
FY25:
−0.84
Change from FY21 to FY25
millions USD
FY21:
0.54
FY22:
13.5
FY23:
54.6
FY24:
37.9
FY25:
30.8
millions USD
FY21:
−1.13
FY22:
−20.6
FY23:
2.46
FY24:
−3.25
FY25:
11.9
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−33.0
FY23:
−51.2
FY24:
−41.2
FY25:
−18.9

All amounts in millions USD Data source:SEC EDGAR